Short-chain fatty acids activate AMP-activated protein kinase and ameliorate ethanol-induced intestinal barrier dysfunction in Caco-2 cell monolayers

Journal of Nutrition

Volumn 143, Issue 12, 2013, Pages 1872-1881

  Elamin, Elhaseen E ^a,b,c   Masclee, Ad A ^a,b,c   Dekker, Jan ^a,d   Pieters, Harm Jan ^b,c   Jonkers, Daisy M ^a,b,c  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETOACETIC ACID; ADENOSINE TRIPHOSPHATE; ALCOHOL; BROMINE DERIVATIVE; BUTYRIC ACID; DEXTRAN; DICHLOROFLUORESCEIN; DIMETHYLTHIAZOL 2 YL 2,5 DIPHENYLTETRAZOLIUM BROMIDE; F ACTIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OCCLUDIN; PROPIONIC ACID; PROTECTIVE AGENT; PROTEIN ZO1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; FATTY ACID;

ARTICLE; BIOLUMINESCENCE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; INTESTINAL BARRIER DYSFUNCTION; METABOLIC STRESS; OXIDATIVE STRESS; PROTEIN FUNCTION; TIGHT JUNCTION; CACO 2 CELL LINE; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; HUMAN; INTESTINE MUCOSA; METABOLISM;

AMP-ACTIVATED PROTEIN KINASES; CACO-2 CELLS; ENZYME ACTIVATION; ETHANOL; FATTY ACIDS; HUMANS; INTESTINAL MUCOSA;

EID: 84888398825     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.179549     Document Type: Article

References (56)

1. Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000; 95:3374-82.
2. Banan A, Choudhary S, Zhang Y, Fields JZ, Keshavarzian A. Ethanol-induced barrier dysfunction and its prevention by growth factors in human intestinal monolayers: evidence for oxidative and cytoskeletal mechanisms. J Pharmacol Exp Ther. 1999; 291:1075-85.
3. Elamin E, Jonkers D, Juuti-Uusitalo K, van Ijzendoorn S, Troost F, Duimel H, Broers J, Verheyen F, Dekker J, Masclee A. Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One. 2012; 7:e35008.
4. Keshavarzian A, Fields JZ, Vaeth J, Holmes EW. The differing effects of acute and chronic alcohol on gastric and intestinal permeability. Am J Gastroenterol. 1994; 89:2205-11.
5. Bjarnason I, Peters TJ, Wise RJ. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984; 1:179-82.
6. Parlesak A, Schafer C, Schutz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000; 32:742-7.
7. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987; 4:8-14.
8. Keshavarzian A, Holmes EW, Patel M, Iber F, Fields JZ, Pethkar S. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage. Am J Gastroenterol. 1999; 94:200-7.
9. Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2004; 286:G881-4.
10. Pöschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004; 39:155-65.
11. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008; 27:104-19.
12. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998; 12:499-507.
13. Hill MJ. Bacterial fermentation of complex carbohydrate in the human colon. Eur J Cancer Prev. 1995; 4:353-8.
14. D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999; 472:149-58.
15. Meijer K, de Vos P, Priebe MG. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Curr Opin Clin Nutr Metab Care. 2010; 13:715-21.
16. Huang N, Wu GD. Short chain fatty acids inhibit the expression of the neutrophil chemoattractant, interleukin 8, in the Caco-2 intestinal cell line. Adv Exp Med Biol. 1997; 427:145-53.
17. Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, Troost FJ, Venema K, Brummer RJ. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr. 2009; 28:88-93.
18. Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy. 2007; 108:354-8.
19. Clausen MR, Bonnen H, Mortensen PB. Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer. Gut. 1991; 32:923-8.
20. Van Deun K, Pasmans F, Van Immerseel F, Ducatelle R, Haesebrouck F. Butyrate protects Caco-2 cells from Campylobacter jejuni invasion and translocation. Br J Nutr. 2008; 100:480-4.
21. Peng L, He Z, Chen W, Holzman IR, Lin J. Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier. Pediatr Res. 2007; 61:37-41.
22. Suzuki T, Yoshida S, Hara H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br J Nutr. 2008; 100:297-305.
23. Mariadason JM, Catto-Smith A, Gibson PR. Modulation of distal colonic epithelial barrier function by dietary fibre in normal rats. Gut. 1999; 44:394-9.
24. Peng L, Li ZR, Green RS, Holzman IR, Lin J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J Nutr. 2009; 139:1619-25.
25. Corton JM, Gillespie JG, Hardie DG. Role of the AMP-activated protein kinase in the cellular stress response. Curr Biol. 1994; 4:315-24.
26. Manzo-Avalos S, Saavedra-Molina A. Cellular and mitochondrial effects of alcohol consumption. Int J Environ Res Public Health. 2010; 7:4281-304.
27. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem. 1995; 229:558-65.
28. Tao N, Sussman S, Nieto J, Tsukamoto H, Yuan JM. Demographic characteristics of hospitalized patients with alcoholic liver disease and pancreatitis in Los Angeles county. Alcohol Clin Exp Res. 2003; 27:1798-804.
29. Uc A, Stokes JB, Britigan BE. Heme transport exhibits polarity in Caco-2 cells: evidence for an active and membrane protein-mediated process. Am J Physiol Gastrointest Liver Physiol. 2004; 287:G1150-7.
30. Swanson G, Forsyth CB, Tang Y, Shaikh M, Zhang L, Turek FW, Keshavarzian A. Role of intestinal circadian genes in alcohol-induced gut leakiness. Alcohol Clin Exp Res. 2011; 35:1305-14.
31. McCarroll JA, Phillips PA, Park S, Doherty E, Pirola RC, Wilson JS, Apte MV. Pancreatic stellate cell activation by ethanol and acetalde-hyde: is it mediated by the mitogen-activated protein kinase signaling pathway? Pancreas. 2003; 27:150-60.
32. Forsyth CB, Tang Y, Shaikh M, Zhang L, Keshavarzian A. Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells. Alcohol Clin Exp Res. 2010; 34:19-31.
33. Banan A, Smith GS, Rieckenberg CL, Kokoska ER, Miller TA. Protection against ethanol injury by prostaglandin in a human intestinal cell line: role of microtubules. Am J Physiol. 1998; 274:G111-21.
34. Zhong W, Zhao Y, McClain CJ, Kang YJ, Zhou Z. Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced down-regulation of intestinal tight junction proteins. Am J Physiol Gastro-intest Liver Physiol. 2010;299:G643-51.
35. Lewis K, McKay DM. Metabolic stress evokes decreases in epithelial barrier function. Ann N Y Acad Sci. 2009; 1165:327-37.
36. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol. 2009; 43:163-72.
37. Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, Banan A, Fields JZ. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxe-mia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009; 50:538-47.
38. Zhong W, McClain CJ, Cave M, Kang YJ, Zhou Z. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2010; 298:G625-33.
39. Lieber CS. Ethanol metabolism, cirrhosis and alcoholism. Clin Chim Acta. 1997; 257:59-84.
40. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci. 2012; 57:3126-35.
41. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001; 81:1031-64.
42. Sun J, Bi L, Chi Y, Aoki K, Misumi J. Effect of sodium acetate on cell proliferation and induction of proinflammatory cytokines: a preliminary evaluation. Food Chem Toxicol. 2005; 43:1773-80.
43. Looby E, Long A, Kelleher D, Volkov Y. Bile acid deoxycholate induces differential subcellular localisation of the PKC isoenzymes beta 1, epsilon and delta in colonic epithelial cells in a sodium butyrate insensitive manner. Int J Cancer. 2005; 114:887-95.
44. Mariadason JM, Barkla DH, Gibson PR. Effect of short-chain fatty acids on paracellular permeability in Caco-2 intestinal epithelium model. Am J Physiol. 1997; 272:G705-12.
45. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004; 127:S87-96.
46. DeSoignie R, Sellin JH. Propionate-initiated changes in intracellular pH in rabbit colonocytes. Gastroenterology. 1994; 107:347-56.
47. Unno N, Menconi MJ, Salzman AL, Smith M, Hagen S, Ge Y, Ezzell RM, Fink MP Hyperpermeability and ATP depletion induced by chronic hypoxia or glycolytic inhibition in Caco-2BBe monolayers. Am J Physiol. 1996;270:G1010-21.
48. Wang A, Si H, Liu D, Jiang H. Butyrate activates the cAMP-protein kinase A-cAMP response element-binding protein signaling pathway in Caco-2 cells. J Nutr. 2012; 142:1-6.
49. Tang Y, Forsyth CB, Banan A, Fields JZ, Keshavarzian A. Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther. 2009; 329:952-8.
50. Cunningham CC, Van Horn CG. Energy availability and alcohol-related liver pathology. Alcohol Res Health. 2003; 27:291-9.
51. Hardie DG. The AMP-activated protein kinase pathway-new players upstream and downstream. J Cell Sci. 2004; 117:5479-87.
52. Zhang L, Li J, Young LH, Caplan MJ. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci USA. 2006; 103:17272-7.
53. Zheng B, Cantley LC. Regulation of epithelial tight junction assembly and disassembly by AMP-activated protein kinase. Proc Natl Acad Sci USA. 2007; 104:819-22.
54. Asai K, Buurman WA, Reutelingsperger CP, Schutte B, Kaminishi M. Modular effects of estradiol on ethanol-induced apoptosis in human intestinal epithelial cells. Scand J Gastroenterol. 2005; 40:326-35.
55. Ma TY, Nguyen D, Bui V, Nguyen H, Hoa N. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol. 1999; 276:G965-74.
56. Rao RK. Acetaldehyde-induced barrier disruption and paracellular permeability in Caco-2 cell monolayer. Methods Mol Biol. 2008; 447:171-83.